Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-02-15 Sale | 2023-02-17 6:09 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.84 | $646,093 | 0 (Direct) | View |
| 2023-02-01 Sale | 2023-02-03 4:59 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 69 | $28.43 | $1,962 | 90,069 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 5:01 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.04 | $626,025 | 265 (Direct) | View |
| 2022-08-24 Sale | 2022-08-26 4:14 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.04 | $625,893 | 530 (Direct) | View |
| 2022-02-01 Sale | 2022-02-03 5:32 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 1,412 | $16.65 | $23,510 | 81,412 (Direct) | View |
| 2020-11-23 Sale | 2020-11-25 4:38 pm | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 29,972 | $23.16 | $694,121 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 17,428 | $7.2 | 0 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A 2025-06-01 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $25.84 | 0 (Direct) | View |
| 2023-02-15 Exercise | 2023-02-17 6:09 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 7,572 | $6.38 | 0 (Direct) | View |
| 2023-01-31 Other | 2023-02-03 4:59 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 69 | $17.32 | 90,069 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-03 4:59 pm | N/A 2033-02-02 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 90,000 | $28.55 | 90,069 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 5:01 pm | N/A 2029-02-06 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $0 | 265 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 5:01 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 3,772 | $6.35 | 265 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 5:01 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 21,228 | $6.38 | 265 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:14 pm | N/A 2024-12-18 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 25,000 | $0 | 530 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:14 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 22,846 | $6.32 | 530 (Direct) | View |
| 2022-07-29 Other | 2022-08-26 4:14 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 265 | $14.12 | 530 (Direct) | View |
| 2022-08-24 Exercise | 2022-08-26 4:14 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 2,154 | $6.35 | 530 (Direct) | View |
| 2022-01-31 Other | 2022-02-03 5:32 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 1,412 | $12.39 | 81,412 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:32 pm | N/A 2032-02-02 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 80,000 | $15.79 | 81,412 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 4:22 pm | N/A 2031-02-03 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2020-11-23 Exercise | 2020-11-25 4:38 pm | N/A 2023-05-09 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 29,972 | $0 | 0 (Direct) | View |
| 2020-11-23 Exercise | 2020-11-25 4:38 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 29,972 | $3.08 | 0 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 4:36 pm | N/A 2030-02-12 | Syndax Pharmaceuticals Inc | SNDX | Ordentlich Peter Chief Scientific Officer | 50,000 | $0 | 50,000 (Direct) | View |